A new and improved process for the preparation of Daclatasvir dihydrochloride been developed for the treatment of hepatitis C (HCV), genotype 3 infections with 99.9% purity and high yield.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report